Evidence map›Paper›PMID 39046237›Full record

Trial reportAntimicrobial agents and chemotherapy2024

Therapeutic efficacy of pyronaridine-artesunate (Pyramax) in treating

Nguyen Duc Manh, Nguyen Van Thanh, Huynh Hong Quang, Nguyen Thi Thanh Van, Nguyen Ngoc San, Nguen Chinh Phong, Geoffrey W Birrell, Kimberly A Edgel, Nicholas J Martin, Michael D Edstein and 1 more

Abstract readClinical Trial
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Antimicrobial agents and chemotherapy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Nguyen Duc ManhVietnam People's Army Military Institute of Preventive Medicine, Hanoi, Vietnam.
Nguyen Van ThanhVietnam People's Army Military Institute of Preventive Medicine, Hanoi, Vietnam.
Huynh Hong QuangVietnam Ministry of Health Institute of Malariology, Parasitology and Entomology, Qui Nhon, Vietnam.
Nguyen Thi Thanh VanVietnam People's Army Military Institute of Preventive Medicine, Hanoi, Vietnam.
Nguyen Ngoc SanVietnam People's Army Military Institute of Preventive Medicine, Hanoi, Vietnam.
Nguen Chinh PhongVietnam People's Army Military Institute of Preventive Medicine, Hanoi, Vietnam.
Geoffrey W BirrellAustralian Defense Force Malaria and Infectious Disease Institute, Brisbane, Australia.
Kimberly A EdgelU.S. Naval Medical Research Unit INDO PACIFIC, Singapore.
Nicholas J MartinU.S. Naval Medical Research Unit INDO PACIFIC, Singapore.
Michael D EdsteinAustralian Defense Force Malaria and Infectious Disease Institute, Brisbane, Australia.
Marina ChavchichAustralian Defense Force Malaria and Infectious Disease Institute, Brisbane, Australia.ORCID 0000-0002-8142-8468

Funding

US Department of Defense Health Program WUN D1430
6 · The paper itself

Abstract

The emergence and spread of chloroquine-resistant CLINICAL TRIALS: This study is registered with the Australian New Zealand Clinical Trials Registry as ACTRN12618001429246.

Indexed as

AntimalarialsArtemisininsArtesunateMalaria, VivaxNaphthyridinesPlasmodium vivaxAdolescentAdultChildChild, PreschoolDrug ResistanceFemaleHumansMaleMembrane Transport ProteinsMiddle AgedAntimalarialsArtemisininsArtesunateCrt-o protein, Plasmodium vivaxMembrane Transport ProteinsNaphthyridinesPrimaquineProtozoan Proteinspyronaridineantimalarial drug resistancemolecular markersPlasmodium vivaxPyramaxpyronaridine-artesunateVietnam

Identifiers

PMID39046237
PMCPMC11373200

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.